Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.05B | 1.95B | 1.82B | 1.86B | 1.81B | 1.86B |
Gross Profit | 1.38B | 1.66B | 754.10M | 884.30M | 874.30M | 908.40M |
EBITDA | 980.20M | 992.70M | 1.18B | 1.19B | 1.16B | 1.06B |
Net Income | 113.20M | 126.90M | 204.90M | -56.80M | 453.40M | 106.80M |
Balance Sheet | ||||||
Total Assets | 16.46B | 15.65B | 14.53B | 14.44B | 14.18B | 14.04B |
Cash, Cash Equivalents and Short-Term Investments | 1.81B | 1.40B | 340.40M | 240.90M | 744.10M | 528.10M |
Total Debt | 10.70B | 10.00B | 8.44B | 7.98B | 8.45B | 8.36B |
Total Liabilities | 14.52B | 13.60B | 12.02B | 11.48B | 11.15B | 11.08B |
Stockholders Equity | 1.94B | 2.06B | 2.51B | 2.96B | 3.03B | 2.96B |
Cash Flow | ||||||
Free Cash Flow | 8.80M | -19.00M | 93.50M | 305.90M | 221.80M | 135.20M |
Operating Cash Flow | 837.50M | 745.10M | 787.50M | 934.40M | 865.80M | 815.20M |
Investing Cash Flow | -1.54B | -731.40M | -593.40M | -639.70M | -555.70M | -598.80M |
Financing Cash Flow | 1.40B | 1.04B | -85.00M | -809.70M | -89.70M | -27.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | £7.93B | 6.43 | 32.10% | 2.70% | -24.74% | -63.34% | |
73 Outperform | £52.18B | 17.27 | 8.35% | 4.32% | -7.42% | 5.84% | |
71 Outperform | £8.26B | 35.44 | 12.73% | 3.92% | 5.38% | 86.34% | |
71 Outperform | £20.32B | 17.07 | 12.29% | 2.29% | -13.09% | 231.40% | |
64 Neutral | £6.81B | 7.05 | 15.34% | 5.46% | 2.03% | -25.14% | |
64 Neutral | £7.78B | 29.40 | 13.05% | 6.06% | 8.61% | ― | |
56 Neutral | £2.32B | ― | -4.44% | 5.97% | 20.25% | -128.71% |